Our board of directors
Our investors are truly the backbone of our company and we value their ongoing support and belief in our mission.
Johan de Ruiter
Chairman
Johan is Chairman of Quanta Dialysis Technologies and former Executive Vice President, Dialysis International at Fresenius AG.
Previously, Johan initiated and founded Fresenius Medical Care AG, with an IPO on the Frankfurt and New York Stock Exchanges after a $4.5B acquisition. Previously he held executive positions with Baxter Healthcare and Abbott Diagnostics. Johan is also Founder of Auxilium Group and LabNet (which was acquired by Amedes Holding GmbH). He is currently a member of btov and is Chairman and board member of CHT Beitlich/BEZEMA Group as well as being Non-Executive Director to several medtech companies. Johan studied at Nyenrode Business University in the Netherlands and at Michigan State University, USA and has an MBA (Hons) in both Marketing and Finance.
John E. Milad
Chief Executive Officer
John is CEO, founding Board Member and an original investor in Quanta Dialysis Technologies.
He is also a regular speaker and panellist at Global MedTech and investment conferences. Previously, John was an investment director at NBGI ventures and has also held various senior positions at healthcare and healthcare investment companies including Horizon Pharma AG (formerly, Nitec Pharma AG), Atlas Venture and Nomura. He has also served as a Director at Cellnovo Limited and Symetis SA. John holds a B.A. in Political Science from the University of Chicago.
Peter Sandys
Non-Executive Director
Peter is Managing Director of Seroba Life Sciences, was a co-founder of Seroba and has held many directorships in the fund management, technology and financial services industries.
Previously, Peter was Managing Director of ABN Amro Corporate Finance (Ireland) Limited, and has held senior positions with Ernst & Young, 3i venture capital and KPMG. Peter has a BBS degree from TCD and is a Chartered Accountant. He has served twice as Chairman of the Irish Venture Capital Association and was a member of the Irish Stock Exchange’s New Issues Committee and the committee of the Irish Bio Industries Association. He was also formerly a member of the Securities Institute, a Registered Stockbroker and a member of the Institute of Taxation in Ireland.
Rainer Strohmenger
Non-Executive Director
Rainer is Managing Partner of Wellington Partners and is one of Europe’s most experienced venture capitalists in Life Sciences.
With over 23 years’ of investment activity, he has been involved in some of the most successful European biotech, medtech, diagnostics and digital health companies. Previously, Rainer was involved in medical research with a primary focus on cardiovascular physiology and in research on health economics at the Ludwig-Maximilians-University in Munich, Germany. Rainer holds a M.D. in medicine as well as a M.S.c in economics, both from Ludwig-Maximilians-University in Munich, Germany and was trained at the Entrepreneurship Center of the MIT, Boston, USA.
Christian Schütz
Non-Executive Director
Christian is a Partner of btov and a member of the Board of Directors also sitting on the Industrial Technologies Fund Team.
Christian focuses on investments in health data, homecare and other health 4.0 technologies. Christian joined btov in 2003 and shared the responsibility for the private investor network, the set-up of the first two btov funds and all btov portfolio investments in the healthcare and resource efficiency sector. Christian earned a PHD in business administration with a focus on venture capital.
Hooman Hakami
Non-Executive Director
Hooman is Managing Director of Hakami Healthcare Advisors, LCC where he provides advisory services to Boards and CEOs in the healthcare space.
Previously, Hooman was Executive Vice President and President of the Diabetes Group at Medtronic and Company Officer at General Electric. Hooman holds a Bachelor of Business Administration (BBA) from the University of Massachusetts Amherst.
Lee Hathaway
Non-Executive Director
Lee is Partner and Co-Head of Healthcare at Glenview Capital Management where he focuses on healthcare services and medical technology investments.
Previously, Lee worked at Water Street Healthcare Partners, a private equity firm focused exclusively on the healthcare industry and for the Global Healthcare Team within the Investment Banking Division of Barclays Capital. Lee holds a B.A. in both economics and history from Duke University in addition to completing the Markets and Management Certificate Program.
Robert Ghenchev
Non-Executive Director
Robert is Senior Partner and Head of Novo Growth. Previously, Robert was Senior Vice President at Moelis & Company in London where he focused on mergers and acquisitions within the Healthcare Industry.
Prior to Moelis, Robert was part of the UK Mergers & Acquisitions Team at Deutsche Bank in London. Robert holds a J.Hons B.A. in Finance and Economics from McGill University and a M.S.c in Financial Economics from the University of Oxford.
